The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma
Open accessAbstract
Acute visceral leishmaniasis is associated with an antigen-specific immunosuppression of mononuclear cells as evidenced by defective in vitro production of interferon gamma. We evaluated treatment with recombinant human interferon gamma in combination with conventional pentavalent antimony therapy in patients with visceral leishmaniasis. Six of eight patients with visceral leishmaniasis (mean duration, 17 months) that had been unresponsive to multiple courses of pentavalent antimony responded to treatment with recombinant human interferon gamma (100 to 400 micrograms per square meter of body-surface area per day) in addition to pentavalent antimony (20 mg per kilogram of body weight per day) for 10 to 40 days. The other two patients improved initially but then relapsed and required treatment with amphotericin B. Eight of nine additional patients with previously untreated severe visceral leishmaniasis were also successfully treated with the combination of interferon gamma and pentavalent antimony. The 14 patients who responded to this regimen had marked improvement in symptoms and in measures of anemia and leukopenia, as well as weight gain, a decrease in spleen size, and an absence or reduction of leishmanias in splenic aspirates. These patients had no recurrence of illness after a mean (+/- SE) follow-up of 8 +/- 1 months. Fever was the only major side effect of interferon gamma. We conclude that the combination of interferon gamma and pentavalent antimony is effective in treating seriously ill patients with refractory or previously untreated visceral leishmaniasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Interleukin l and T Cell Activation
Mizel, S. B. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb00411.x · Cited by 613
Response of resting human peripheral blood natural killer cells to interleukin 2.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., & Perussia, B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1147 · Cited by 604
Interleukin 1: An Immunological Perspective
Durum, S. (1985) · Annual Review of Immunology · doi:10.1146/annurev.immunol.3.1.263 · Cited by 580
New Perspectives on a Subclinical Form of Visceral Leishmaniasis
Badaro, R., Jones, T. C., Carvalho, E. M., Sampaio, D., Reed, S. G., Barral, A., Teixeira, R., & Johnson, W. D. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.6.1003 · Cited by 480
Self-citationSteeg, P. S., Moore, R. N., Johnson, H. M., & Oppenheim, J. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1780 · Cited by 475
Murray, H. W., Rubin, B. Y., & Rothermel, C. D. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111107 · Cited by 400
Spitalny, G. L., & Havell, E. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.5.1560 · Cited by 367
Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray, H. W., Spitalny, G. L., & Nathan, C. F. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1619 · Cited by 355
Nathan, C. F., Kaplan, G., Levis, W. R., Nusrat, A., Witmer, M. D., Sherwin, S. A., Job, C. K., Horowitz, C. R., Steinman, R. M., & Cohn, Z. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150102 · Cited by 323
Cited by
A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape Mechanism
Barral-Netto, M., Barral, A., Brownell, C. E., Skeiky, Y. A. W., Ellingsworth, L. R., Twardzik, D. R., & Reed, S. G. (1992) · Science · doi:10.1126/science.1636092 · Cited by 434
Self-citationCytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 408
Holland, S. M., Eisenstein, E. M., Kuhns, D. B., Turner, M. L., Fleisher, T. A., Strober, W., & Gallin, J. I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301904 · Cited by 302
Metadata
- Authors
- Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., Bina, J. C., Teixeira, R., Falcoff, R., Rocha, H., Ho, J. L., & Johnson, W. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-01-04
- Volume
- 322
- Issue
- 1
- Pages
- 16-21
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2317008929
- Cited by
- 310
- References
- 19
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma. https://app.cochat.ai/papers/10.1056/nejm199001043220104
- The paper
- Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., Bina, J. C., Teixeira, R., Falcoff, R., Rocha, H., Ho, J. L., & Johnson, W. D. (1990). Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma. New England Journal of Medicine. https://doi.org/10.1056/nejm199001043220104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.